Navigation Links
LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
Date:1/16/2012

reting insulin, the hormone that controls the level of glucose in the blood. Preliminary experiments in mice indicate the compounds have little toxicity. "Isoxa­zole is among relatively few single molecules known that can improve beta-cell function dramatically," the study concludes.

Diabetes is a group of metabolic diseases in which a person has high blood sugar, either because the body does not produce enough insulin (type 1 diabetes), or because cells do not respond to the insulin that is produced (type 2 diabetes). More than one-third of the U.S adult population is at risk for type 2 diabetes, the most prevalent form of the disease. During the development of type 2 diabetes, beta cells become progressively unable to produce insulin, causing the blood sugar to rise dangerously, leading to increased risk of heart attacks, strokes, diabetic retinopathy where eye sight is affected, and kidney failure.

The research is part of LoneStar Heart's broad program of developing small molecules and proteins that have the capacity to switch native, cardiac stem cells into adult heart muscle cells as a means of restoring and repairing damaged heart tissue. These mechanisms are typically repressed in adult hearts injured by myocardial infarction, advanced age, and other diseases.

About LoneStar Heart Inc.

LoneStar Heart Inc. is developing cardiac restorative therapies for patients with heart fail­ure that harness the heart's ability to repair itself. Based on its integrated cardiomechanical and biomolecular technologies, the privately held company is advancing a broad portfolio of pro­ducts to restore the failing heart's structure and function in collaboration with the Texas Heart Institute, UT Southwestern, and a global network of leading clinicians. These products include Algisyl-LVR™, cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the co
'/>"/>

SOURCE LoneStar Heart Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
2. Post Heart Attack Recovery Not Aided By Stem Cell Injections, But Trial Demonstrates Promise
3. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
4. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
5. CU-Boulder python study may have implications for human heart health
6. New England Research Institutes (NERI) Announces Additional $45M NIH Grant to Support the Pediatric Heart Network
7. HeartWare Schedules Third Quarter Conference Call and Webcast
8. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
9. HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient
10. Total Artificial Heart Patient Enjoys Spotlight as "The Only Man in Turkey Who Lives Without a Heart"
11. HeartWare to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... announces the launch of their 2nd generation cell therapy POD® design. The 2nd ... but it also represents a new POD® design. , “G-CON first offered ...
(Date:7/29/2015)... Inc., an early stage biotech startup based on perinatal ... the Musculoskeletal Transplant Foundation of Edison NJ ... round of development of the proprietary AmnioCept™ product line ... AmnioChor,s technology allows cryopreservation of the amniotic membrane of ... those tissues. Amnion is a well-established source of multipotent ...
(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
... (Nasdaq:,NUVA), a medical device company focused on developing products ... relating to its second quarter 2008 earnings announcement, which,will ... close of the market., NuVasive will hold a ... ET / 2:30 p.m. PT to discuss the results. ...
... Insmed Inc.,(Nasdaq CM: INSM), a developer of follow-on ... that the,Company has retained the services of RBC ... advisor., "Insmed,s Board of Directors and senior ... will be utilizing RBC,s experience and,expertise to examine ...
... Cepheid (Nasdaq:,CPHD) today announced that it will report ... 2008, on Thursday, July 24, 2008 after the,close of ... presentation at 1:30 p.m. Pacific,Time on Thursday, July 24, ... please visit Cepheid,s website at http://www.cepheid.com/investors ,at least ...
Cached Biology Technology:NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results 2NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results 3Insmed Retains RBC Capital Markets as Strategic Financial Advisor 2Insmed Retains RBC Capital Markets as Strategic Financial Advisor 3Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast 2
(Date:7/7/2015)... Calif. , July 7, 2015  Based ... market, Frost & Sullivan recognizes Credence ID, LLC ... Entrepreneurial Company of the Year Award. Credence ... to aid in its mission of offering enrollment ... populations globally. As Credence ID was formed by ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint Cards ... FPC1035, FPC1145 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... sensors will be used by smartphone manufacturers in ... included in the communicated revenue guidance of approximately 2,200 MSEK ...
(Date:6/26/2015)... 2015 ATL Technology, LLC, a top provider of ... single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Costa Rica ). This acquisition will incorporate ... with ATL Technology,s existing facility in Costa Rica ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Recognizing faces is an important social skill, but not all ... unable to recognize even their closest friends (a condition called ... of faces. Now a twin study by collaborators at MIT ... and that it is inherited separately from general intelligence or ...
... observer in the Gulf of Mexico, the seemingly sluggish red ... beaver. But a new study led by researchers at The ... and ecosystem engineer. Most abundant along Florida,s west coast ... caverns from North Carolina to Brazil, the red grouper excavates ...
... City, Mexico and Cambridge, MA, USA Tuesday, January 19 ... of a major research project in genomic medicine that will ... the world. The project will be carried out by ... Broad Institute of MIT and Harvard and the National Institute ...
Cached Biology News:Face recognition ability inherited separately from IQ 2Face recognition ability inherited separately from IQ 3New study reveals red grouper to be 'Frank Lloyd Wrights of the sea' 2New study reveals red grouper to be 'Frank Lloyd Wrights of the sea' 3Mexico-US collaboration launched to study major human diseases 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
... of the Art GLP facility with ... 38,000 L fermentation. Coordinated process ... Aseptic operation capable of simultaneous ... Continuous Modes. Hosts include: Bacteria, ...
Competitors to lower non-specific signal...
Biology Products: